# Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.

> **NCT05226702** · PHASE1 · COMPLETED · sponsor: **University of Saskatchewan** · enrollment: 60 (actual)

## Conditions studied

- Double Vaccinated for COVID-19 (For Phase 1 of the Study)
- Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)

## Interventions

- **BIOLOGICAL:** COVAC-2
- **BIOLOGICAL:** Saline Placebo

## Key facts

- **NCT ID:** NCT05226702
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-22
- **Primary completion:** 2023-11-13
- **Final completion:** 2023-11-13
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-05-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05226702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05226702, "Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05226702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*